Fundraising FoxOsage University Partners — Full Portfolio
47 tracked investments · listed companies and verified rows first
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+20 more
A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.
BiotechMedia & EntertainmentAustin, US
Matthew Winkler(Director)Sinil Kim(Executive Officer)inPaul Lammers(Executive Officer, Director)inJon Irvin(Executive Officer)Casi DeYoung(Executive Officer)
BoardMichael Powell(Director)
Co-investorsNew Enterprise Associates (NEA)Pfizer Venture InvestmentsCorrelation VenturesOrbiMedOUP (Osage University Partners)Pfizer Ventures+1 more
Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.
BiotechHealthtechMedical DevicesSan Diego, US
Marc Nasoff(Chief Scientific Officer)
BoardJay B. Lichter(Ph.D.)in
Co-investorsVivo CapitalLilly Asia VenturesAvalon BioVenturesOUP (Osage University Partners)
Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.
BiotechDigital HealthChapel Hill, US
Jenny Ting(Director and Co-founder)Anil Goyal(CEO and Director)
Co-investorsDelin VenturesHatteras Venture PartnersOUP (Osage University Partners)
Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team.
BiotechHealthtechSouth San Francisco, US
Kathleen Collins(Director)inLawrence Kong(Executive Officer)inRon Park(President & CEO)inFrancine Gregoire(Chief Scientific Officer)inPriya Parameswaran(Chief Business Officer)in
BoardJayson Punwani(Director)in
Co-investorsBEVCPivotal Life SciencesSR One Capital ManagementAbingworth
Algorithmia offers an enterprise AI platform for developing, deploying, and governing machine learning models and AI applications, with tooling tailored to roles across data science, engineering, DevOps, and IT teams.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSeattle, US
Kenneth F. Daniel(Executive Officer, Director)Diego M. Oppenheimer(Executive Officer, Director)in
BoardTimothy Porter(Director)inAnna Patterson(Director)in
Co-investorsGradient VenturesMadrona Venture GroupOUP (Osage University Partners)Norwest Venture PartnersWork-Bench
Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Michael Gilman(Executive Officer, Director)inMark DeLong(CEO)inDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)
BoardColleen Cuffaro(Director)inAlan E. Walts(Director)in
Co-investorsCanaan PartnersPfizer VenturesAdvent Life SciencesHBM Healthcare InvestmentsHBM PartnersNextech Invest+3 more
AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.
Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US
William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in
Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+5 more
Brimstone develops co-production processes to manufacture cement, steel, aluminum, and other critical minerals from a single feedstock in an integrated facility.
Advanced ManufacturingCircular EconomyCleantechConstruction TechNew MaterialsOakland, US
Cody Finke(Co-founder & CEO)inHugo Leandri(Co-founder; Senior Advisor)inCody Finke, Ph.D.(Founder)in
Co-investorsAccelr8Breakthrough Energy VenturesCollaborative FundCreative Destruction Lab (CDL)DCVC (Data Collective)Fifth Wall+8 more
Clarifai developed AI inference technology and compute orchestration software for running and optimizing machine learning models at scale.
AI & Machine LearningCloud ComputingData & InfrastructureNew York, US
Matthew Zeiler(Executive Officer, Director)in
BoardAlbert Wenger(Director)in
Co-investorsBright Pixel CapitalCorazon CapitalGV (Google Ventures)Lux CapitalMenlo VenturesNew Enterprise Associates (NEA)+11 more
BiotechBurlingame, US
Mark Rolfe(Executive Officer)Laura Shawver(Executive Officer, Director)inTimothy Smith(Executive Officer)
BoardAlfred Scheidegger(Director)inPeter Thompson(Director)inCarol Gallagher(Director)in
Co-investorsAstellas Venture Management LLCNew Enterprise Associates (NEA)Nextech InvestOUP (Osage University Partners)5AM VenturesClarus Ventures+2 more
Corelight provides network detection and response (NDR) software that uses agentic triage to automatically consolidate security alerts into entity-centric cases with evidence-backed investigation summaries.
AI & Machine LearningCybersecurityEnterprise Software
Co-investorsAccelCisco InvestmentsDelta-v CapitalEnergy Impact PartnersFlucas VenturesH.I.G. Capital+7 more
Crozet, US
Randy Caldejon(Chairman, Chief Executive Officer and President)Erik Breuhaus(Chief Financial Officer)Peter Shaw(Vice President)in
BoardMatthew Swartz(Director)
Co-investorsOUP (Osage University Partners)TFX CapitalTiburon
Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.
BiotechHealthtechCambridge, US
Kevin Mills(Executive Officer, Director)inRonald Goldstein(Executive Officer)inDonald Corcoran(Executive Officer, Director)inMarkus Renschler(Director)in
BoardTimothy Romberger(Director)Barry Mills(Director)
Co-investorsDroia VenturesLightstone VenturesOUP (Osage University Partners)Shah Family OfficeAlly Bridge GroupDe Novo Ventures+4 more
DualEntry is an AI-native enterprise resource planning (ERP) platform designed to replace legacy accounting systems for mid-market to enterprise businesses.
AI & Machine LearningEnterprise SoftwareFintechSaaSNew York, US
Santiago Nestares(Co-founder)inBenedict Dohmen(Founder)in
Co-investorsContraryGV (Google Ventures)Khosla VenturesLightspeed Venture PartnersCarya Venture PartnersLudlow Ventures+10 more
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+13 more
Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
BiotechSan Diego, US
Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)
BoardAndrew Schwab(Director)in
Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column Group+3 more
Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.
HardwareIoTSemiconductorsSan Jose, US
Benton Calhoun(CEO and Co-Founder)inDavid Wentzloff(CTO and Co-Founder)inBrendan R Richardson(Executive Officer, Director)
BoardGeorge Kastendike(Director)Greg Papadopoulos(Director)inJack Busch(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalBlue Bear Capital PartnersNew Enterprise Associates (NEA)OUP (Osage University Partners)ABB Technology VenturesFluke Venture Partners+1 more
Hack VC is a venture capital firm that invests in early-stage web3, crypto, and AI startups, with focus areas including decentralized infrastructure, DeFi, privacy-preserving technologies, and cryptography.
AI & Machine LearningCrypto & Web3Fintech
Alex(Co-founder & Managing Partner)Ed(Co-founder & Special Advisor)
Co-investorsCircle VenturesEvolution VC PartnersNimble PartnersSerafundUncorrelated VenturesWeb3com Ventures+5 more
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.
HealthtechMedical DevicesLexington, US
Carl Vause(Executive Officer, Director)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)
BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in
Co-investorsCanaan PartnersOUP (Osage University Partners)Treo Ventures, LlcJohnson & Johnson Innovation – JJDC
BiotechPhiladelphia, US
Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)Lori Forrest(Executive Officer)Leon Moulder, Jr.(Director)Benjamin Lund(Director)in
BoardTomas Kiselak(Director)
Co-investorsAgent CapitalDC Investment PartnersLongwood FundOUP (Osage University Partners)Pfizer Venture InvestmentsQuan Capital+3 more
BiotechSan Diego, US
Kevin Forrest, Ph.D.(Executive Officer, Director)
BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)
Co-investorsOUP (Osage University Partners)Westlake Village BioPartnersKleiner PerkinsVersant Ventures
Vertically-integrated machine learning platform for healthcare powering transition to value-based care with predictive analytics.
Co-investorsMindset VentureOUP (Osage University Partners)Polaris Partners
Kymeta develops flat-panel satellite antennas and connectivity terminals, including its u5 and u8 product lines, that switch between LEO and GEO networks for mobile land and maritime use.
Defense TechHardwareSpace TechRedmond, US
Marc Stolzman(Executive Officer)inBill Marks(Executive Officer)Keith Cochran(Executive Officer)inManny Mora(CEO)inAnne(Chief Financial Officer)inRyan(Chief Scientist)in
Co-investorsLux CapitalManta Ray VenturesOUP (Osage University Partners)Tectonic Ventures
San Diego, US
Bob Kain(Executive Officer, Director)inDawn Barry(Executive Officer)inJoseph C. Beery(Executive Officer, Director)
Co-investorsARCH Venture PartnersBain Capital VenturesF-Prime CapitalIllumina Ventures
Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.
Deep TechHardwareSemiconductorsStoneham, US
Federico Capasso(Co-founder)inRob Devlin(Co-Founder and CEO)in
BoardXuhui Shao(Director)in
Co-investorsBantam GroupBraemar Energy VenturesFoothill VenturesGlobal BrainIntel CapitalM Ventures+7 more
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+6 more
Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.
BiotechHealthtechMedical DevicesWatertown, US
MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in
Co-investorsCanaan PartnersF-Prime CapitalLumira VenturesMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)
Opsys develops solid-state scanning LiDAR sensors with no moving parts, using VCSEL and SPAD chip technology for autonomous driving and industrial applications.
AI & Machine LearningDeep TechHardwareRoboticsIsrael, IL
Co-investors83NorthOUP (Osage University Partners)Saban VenturesTransLink Capital
Overland AI develops ground autonomy solutions for military vehicles and land operations, enabling autonomous mobility without human operators.
AI & Machine LearningDefense TechRoboticsSeattle, US
Byron Boots(Co-Founder & CEO)inStephanie Bonk(Co-Founder & President)inGreg Okopal(Co-Founder & COO)inJonathan Fink(Executive Officer)
BoardChristopher Morales(Director)
Co-investors8VCAlumni VenturesAscend Venture CapitalCubit CapitalOUP (Osage University Partners)Overmatch+8 more
Picwell operates ALEX, a benefits decision-support platform that combines plan recommendations, enrollment, benefits administration, and year-round guidance for employees.
HR TechInsurTechSaaSPhiladelphia, US
Thomas Baker(Executive Officer, Director)Jonathan Thompson Kolstad(Executive Officer, Director)Robert James Town(Executive Officer, Director)Jay Silverstein(Executive Officer, Director)inAnirudh Vemprala(Executive Officer, Director)
BoardKevin Hill(Director)
Co-investorsBlue Venture FundsMassMutual VenturesOUP (Osage University Partners)SeaX VenturesBlueCross BlueShield Venture Partners
PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function.
BiotechHealthtechCranbury, US
David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Director)
BoardPeter Thompson(Director)inSteve Winick(Director)Arnold Oronsky(Director)
Co-investorsAvoro Capital AdvisorsNextech InvestOUP (Osage University Partners)RA CapitalViking GlobalWellington Management+1 more
Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.
AI & Machine LearningBiotechDigital HealthBoston, US
Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)inSylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)inToni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)
Co-investors5AM VenturesIllumina VenturesOUP (Osage University Partners)AlexandriaLilly Asia VenturesS28 Capital
BiotechLexington, US
Victoria M. Richon(Executive Officer, Director)in
BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)
Co-investorsAvego BioScience CapitalOUP (Osage University Partners)Peregrine VenturesAbbVieDeerfield Management CompanyJJDC+4 more
Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).
BiotechHealthtechMedical DevicesSouth San Francisco, US
John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)inRob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)
Co-investorsOUP (Osage University Partners)Vivo CapitalWellington ManagementLumira VenturesRA CapitalRed Tree Venture+1 more
Seismos provides an AI intelligence layer that converts acoustic signals and sensor measurements into real-time completion decisions for oil and gas well operators.
AI & Machine LearningDeep TechEnergyAustin, US
Panagiotis Adamopoulos(Executive Officer, Director)Panos Adamopoulos(Founder)inJeffrey Harris(Director)John Bain(Director)
BoardNoah Doyle(Director)in
Co-investorsEdison PartnersJavelin Venture PartnersOUP (Osage University Partners)
SunPower provides residential solar systems, installing monocrystalline solar panels on homeowners' roofs to lower electricity bills and reduce carbon emissions.
CleantechClimate TechEnergyHardwareSan Jose, US
Dick SwansoninWill Anderson(Co-founder)Dave Anderson(Co-founder)Patrick Chapman(Executive Officer)inPhilip T. Krein(Director)Eric Branderiz(Executive Officer)in
Co-investorsEcosystem Integrity FundPrelude VenturesBattery VenturesConstellation Technology VenturesRho Ventures
Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.
BiotechDeep TechSouth San Francisco, US
Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)in
BoardMichael Goller(Director)Reid Huber(Director)inPeter Thompson(Director)in
Co-investorsEcoR1 CapitalOrbiMedRA CapitalNovo HoldingsThird Rock Ventures
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases.
BiotechDigital HealthMedical Devices
Geoff von Maltzahn(Founder)inJoseph Romanelli(CEO)
Co-investorsArtis VenturesFlagship PioneeringMarch Capital PartnersOMX VenturesSoftBank Vision FundSolari Capital+4 more
Tessera provides a multi-agent AI platform for enterprise system modernization, automating processes across ERP, CRM, HCM, and finance systems with governed execution.
AI & Machine LearningEnterprise SoftwareSaaS
Kabir Nagrecha(Chief Executive Officer)inMing Chang(Chief Operating Officer)inAnirudh Sriram(Chief Technology Officer)inPrakash Gupta(Chief Revenue Officer)in
Co-investorsAndreessen HorowitzClear VenturesFoundation CapitalOUP (Osage University Partners)Myriad Venture Partners
Vanqua Bio is a biotechnology company developing molecules intended to become medicines for neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, and related neurological conditions.
BiotechDeep TechHealthtechLongevityChicago, US
Rand Sutherland(Director)inJames Sullivan(Executive Officer, Director)inJim Sullivan(CEO)inKevin Hunt(CSO)in
BoardJonathan Silverstein(Director)inBernard Davitian(Director)
Co-investorsAvoro Capital AdvisorsOrbiMedOUP (Osage University Partners)Pontifax Venture CapitalAvoro VenturesCasdin Capital+1 more
FintechSan Francisco, US
Co-investorsLightspeed Venture PartnersTechstarsTomorrow Today ASWalden Catalyst
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AtterocorBlade TherapeuticsMerganser BiotechNido BiosciencesSynthorx
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.